Comparison of S1 antibody titers between BNT162b2 and ChAdOx1 COVID-19 vaccination in cancer patients

Affiliations

• ¹ Multidisciplinary Oncological Center Antwerp (MOCA), Antwerp University Hospital, Edegem; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp and Antwerp University Hospital, Edegem.
• ² Multidisciplinary Oncological Center Antwerp (MOCA), Antwerp University Hospital, Edegem.
• ³ Department of Laboratory Medicine, Antwerp University Hospital, Edegem.
• ⁴ Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp and Antwerp University Hospital, Edegem; GeIntegreerd Kankercentrum Gent (IKG), AZ Maria Middelares, Ghent, Belgium.
• ⁵ Multidisciplinary Oncological Center Antwerp (MOCA), Antwerp University Hospital, Edegem; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp and Antwerp University Hospital, Edegem. Electronic address: marc.peeters@uza.be.